Skip to main content
. Author manuscript; available in PMC: 2016 Mar 18.
Published in final edited form as: Leuk Lymphoma. 2015 Oct 12;57(3):635–643. doi: 10.3109/10428194.2015.1075019

Table II.

Grade 3 and 4 hematologic and non-hematologic toxicities occurring during any treatment course and deemed possibly, probably, or definitely related to the treatment

# of events, # of patients (% of patients)
Hematologic toxicities Grade 3 Grade 4
Anemia 3, 3 (15) 0, 0 (0)
Lymphocyte count decreased 2, 1 (5) 0, 0 (0)
Neutrophil count decreased 6, 5 (25) 1, 1 (5)
Platelet count decreased 2, 2 (10) 0, 0 (0)
White blood cell decreased 5, 3 (15) 2, 2 (10)

# of events, # of patients (% of patients)
Non-hematologic toxicities Grade 3 Grade 4

Dyspnea 1, 1 (5)* 0, 0 (0)
Febrile neutropenia 1, 1 (5) 0, 0 (0)
Hypokalemia 1, 1 (5) 0, 0 (0)
Hyponatremia 2, 2 (10) 0, 0 (0)
Pneumonitis 1, 1 (5)* 0, 0 (0)
*

Dyspnea and pneumonitis were observed in the same patient.